A Novel Investigational Treatment for Hypersomnia with Christopher L. Drake PhD, FAASM

At #BeyondSleepy 2024 in Houston, TX, Dr. Christopher Drake discusses the clinical trial of KP1077 on behalf of Zevra Therapeutics.

Christopher L. Drake, PhD, FAASM is an internationally recognized expert in sleep and circadian rhythm disorders. He is professor of medicine at the Michigan State College of Human Medicine and serves as the Director of Sleep Research for Henry Ford Health. He is the Insomnia Section Editor for Principles and Practice of Sleep Medicine and serves as Associate Editor for SLEEP, Sleep Advances, and Behavioral Sleep Medicine. He served as Chairman of the National Sleep Foundation from 2013-2014 and received
the Distinguished Service Award from the Sleep Research Society in 2015. In 2016, Dr. Drake Received the Pioneer Award from the Robert Wood Johnson Foundation. He has been funded by the National Institutes of Health since 2004 and has authored over 200 publications.

If this video is helpful to you, please consider donating to HF. Your donation makes these resources possible! https://www.hypersomniafoundation.org...